MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
GRAL — GRAIL, Inc. Common Stock
NasdaqGRAIL, Inc. Common Stock
$143.26
+10.70(+8.07%)
- O
- 135.52
- H
- 143.50
- L
- 134.45
- V
- 871.96K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About GRAL
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateJun 12, 2024
Employees910
Stock ExchangeNasdaq
Ticker SymbolGRAL
Websitehttps://www.grail.com
Key Financial Statistics
| Market Cap | $6.40B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $41.50 - $151.46 |
| 52-Week Avg Volume | 996.3K |
| VWAP | $140.81 |
| Transactions | 20,712 |
| Total Recorded Bars | 578 days |